Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-59420
Front Pharmacol 2022 Jan 01;13:1022275. doi: 10.3389/fphar.2022.1022275.
Show Gene links Show Anatomy links

Voltage dependence of the cannabinoid CB1 receptor.

Goldberger E , Tauber M , Ben-Chaim Y .


???displayArticle.abstract???
Cannabinoids produce their characteristic effects mainly by binding to two types of G-protein coupled receptors (GPCRs), the CB1 and CB2 cannabinoid receptors. The CB1 receptor is the main cannabinoid receptor in the central nervous system, and it participates in many brain functions. Recent studies showed that membrane potential may serve as a novel modulatory modality of many GPCRs. Here, we used Xenopus oocytes as an expression system to examine whether membrane potential modulates the activity of the CB1 receptor. We found that the potencies of the endocannabinoid 2-AG and the phytocannabinoid THC in activating the receptor are voltage dependent; depolarization enhanced the potency of these agonists and decreased their dissociation from the receptor. This voltage dependence appears to be agonist dependent as the potency of the endocannabinoid anandamide (AEA) was voltage independent. The finding of this agonist-specific modulatory factor for the CB1 receptor may contribute to our future understanding of various physiological functions mediated by the endocannabinoid system.

???displayArticle.pubmedLink??? 36304142
???displayArticle.pmcLink??? PMC9592857
???displayArticle.link??? Front Pharmacol


Species referenced: Xenopus laevis
Genes referenced: kcnj3 was
GO keywords: G-protein coupled receptor activity [+]


???attribute.lit??? ???displayArticles.show???
References [+] :
An, Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. 2020, Pubmed